Full-Time

Category Buyer Raw Materials

Bioprocess Materials, Consumable, Sut, Chromatog, Resin, Media

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Framingham, MA, USA + 1 more

More locations: East Side, PA, USA

Category
Procurement & Sourcing
Supply Chain Management
Operations & Logistics
Requirements
  • 5 years' experience in Procurement/Buying within Pharmaceuticals, Aerospace, Automotive or FMCG.
  • Bachelor’s degree from accredited University.
  • Supplier landscape know-how & demonstrated track record of achieving significant cost savings.
  • Strong understanding of raw materials’ procurement value chain from R&D up to LCM, their supply chain dynamics and industry trends.
  • Good knowledge of bioprocess suppliers' landscapes along with their respective capabilities.
  • Strong negotiation and contract management skills with the ability to lead complex supplier relationships.
  • Excellent command of English is a must. French is a plus.
Responsibilities
  • Develop innovative sub-category strategies that have measurable benefit for Sanofi.
  • Negotiate worldwide and deliver savings based on anticipation and consolidation of all business needs.
  • Drive major transversal category initiatives to build up state of the art practices and innovation in sourcing.
  • Leverage both generative and predictive Artificial Intelligence in sourcing, scenario, and result augmentation.
  • Ensure procurement technical excellence such as TCO, SRM, Market Intelligence, Risk Management, Innovation, Digital, CSR, HSE, compliance, quality at Global Level.
  • Manage Global Business Reviews with strategic partners to ensure ambition and execution in both sides.
  • Directly impact a €10 billion company revenue and support over 6 product launches in new vaccines over the next 5 years.
  • Oversee key account management for strategic suppliers managing relationships.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical needs. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of products. The company's goal is to enhance health outcomes and improve the quality of life for people globally.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's AI tool Muse accelerates patient recruitment in clinical trials.
  • Dupixent's EU approval expands Sanofi's pediatric treatment market.
  • BrightInsight partnership enhances digital health solutions for better patient outcomes.

What critics are saying

  • Increased competition in the rare disease sector from biotech startups.
  • Regulatory risks due to liver enzyme elevations in tolebrutinib trials.
  • Dependence on strategic partnerships like BrightInsight for digital health initiatives.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.

Help us improve and share your feedback! Did you find this helpful?